Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Studies from Sichuan University describe new findings in cancer vaccines
August 25th, 2008
"Dendritic cells (DCs) are important cells in initiating an immune response. A generation of functional DO has potential clinical use in treating cancer," scientists in Chengdu, People's Republic of China report. "However, the source of DCs and patient immunodeficiency with cancer have been hindrances in clinical therapy. We generated DCs from human umbilical cord blood mononuclear cells (UBMCs) with recombinant human granulocyte-macrophage colony stimulating factor, recombinant human interleukin-4, and recombinant human tumor necrosis factor-a. The mature DC-A549 lung cancer vaccine (AgL-DC) was prepared through loading A549 lysate, treating with lipopolysaccharide...
Source: Stem Cell Week (2008-08-25)
|
